Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancer
โ Scribed by Fuks, Joachim Z. ;Patel, Halesh ;van Echo, David A. ;Hornedo, Javier ;Aisner, Joseph
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 449 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The drug combination of mitomycin-C, cisplatin, and vinblastine was administered to 30 patients with stage III non-small-cell lung cancer. All patients had a performance status of 50% or greater, had evaluable disease, and had not received previous chemotherapy. The overall response rate was 37% wit
## BACKGROUND. Tamoxifen sensitizes cancer cells to chemotherapeutic agents. High dose tamoxifen has been tested in the treatment of patients with melanoma and other cancers. The authors conducted a Phase II study of high dose tamoxifen plus cisplatin and etoposide for patients with advanced, inop